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Abstract
Background: The control of Mycobacterium tuberculosis (Mtb) infection begins with the recognition of
mycobacterial structural components by toll like receptors (TLRs) and other pattern recognition receptors. Our
objective was to determine the influence of TLRs polymorphisms in the susceptibility to develop tuberculosis (TB)
in Amerindian individuals from a rural area of Oaxaca, Mexico with high TB incidence.
Methods: We carried out a case–control association community based study, genotyping 12 polymorphisms of
TLR2, TLR4, TLR6 and TLR9 genes in 90 patients with confirmed pulmonary TB and 90 unrelated exposed but
asymptomatic household contacts.
Results: We found a significant increase in the frequency of the allele A of the TLR9 gene polymorphism rs352139
(A>G) in the group of TB patients (g.f. = 0.522) when compared with controls (g.f. = 0.383), (Pcorr = 0.01,
OR = 1.75). Under the recessive model (A/G + A/A vs G/G) this polymorphism was also significantly associated with
TB (Pcorr = 0.01, OR= 2.37). The association of the SNP rs352139 was statistically significant after adjustment by age,
gender and comorbidities by regression logistic analysis (Dominant model: p value = 0.016, OR = 2.31; Additive
model: p value = 0.023, OR = 1.68). The haplotype GAA of TLR9 SNPs was also associated with TB susceptibility
(Pcorr = 0.02). Differences in the genotype or allele frequencies of TLR2, TLR4 and TLR6 polymorphisms between TB
patients and healthy contacts were not detected.
Conclusions: Our study suggests that the allele A of the intronic polymorphism rs352139 on TLR9 gene might
contribute to the risk of developing TB in Mexican Amerindians.
Keywords: Tuberculosis, rs352139, TLRs, Gene polymorphisms, Susceptibility, TLR9
Background
Tuberculosis (TB) is a leading cause of death worldwide
[1]. World Health Organization (WHO) estimates one-
third of the world’s population is infected with Mycobacter-
ium tuberculosis (Mtb) [2] and between the 2000 and 2020,
about one billion people will become infected and 200
million people will develop active TB. Only 5 to 10% of the
infected individuals develop the clinically active disease in
their lifetime and the other 90% remain as latently Mtb
infected individuals [2-4]. The progression to active TB is
the result of the interplay between environmental, host
genetic factors and pathogenic characteristics of the Mtb
strain [3-6].
Multiple genes have been involved in the control of Mtb
and progression to TB [7,8]. In this context, toll like recep-
tors (TLRs) are a family of phylogenetically conserved
genes, which are essential for recognition of a broad reper-
toire of pathogen-associated molecular patterns (PAMPs)
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role in the innate responses against Mtb [9-13].
Genetic variations of TLR1, TLR2, TLR4, TLR6 and
TLR9 have been associated with the susceptibility to TB
in different ethnic groups [14-20]. In contrast, other
studies have failed to demonstrate significant associa-
tions of TLRs polymorphisms with TB [21-24].
To our knowledge, no previous studies have addressed
the prevalence of TLRs polymorphisms in Mexican
patients with TB. Therefore, we examined whether poly-
morphisms in TLR2, TLR4, TLR6 and TLR9 are associ-
ated with the susceptibility to pulmonary TB in Mexican
individuals from a rural area with high incidence of TB.
Materials and methods
Subjects
Samples from 180 unrelated individuals (90 patients with
diagnosis of pulmonary TB and 90 household healthy
controls) were obtained. The diagnosis of pulmonary TB
was based on the WHO criteria with presence of clinical
symptoms, detection of acid-fast bacilli in sputum smear
samples, Mtb positive cultures in Löwenstein-Jensen
medium and X-ray evidence of cavitary lesions in lung.
Only patients older than 18 years were included in the
study. As a control group, we included unrelated indi-
viduals that were in close contact with TB patients, all of
them were asymptomatic and no evidence of positive
Mtb cultures or radiological lesions in lung were
detected. Both, TB patients and controls were recruited
from the programs of TB detection and control in the
State of Oaxaca and were from the Mazatecan ethnic
group and were living in the Town called Temascal, a
rural area near from the City of Tuxtepec in Oaxaca
State (a high pulmonary TB incidence area located in
the southeast of Mexico). All studied individuals; their
parents and grandparents were born in the Mazatecan
area in Oaxaca State, Mexico. The clinical and demo-
graphic characteristics of TB patients and controls are
shown in Table 1.
The Institutional Review Board (IRB) of the National
Institute of Respiratory Diseases (INER) reviewed and
approved the protocol under which all subjects were
recruited. All subjects provided written informed con-
sent for these studies, and they authorized the storage of
their DNA samples at INER repositories for this study.
DNA isolation and TLR 2, 4, 6 and 9 SNP genotyping
Genomic DNA was isolated from EDTA-anticoagulated
peripheral blood by using Qiagen blood mini kit (Qiagen,
Chatsworth, CA). A total of 12 SNPs at the TLR2 (rs38
04099, rs7656411, rs121917864, and rs5743708), TLR4
(rs5030710, rs5030725, rs12344353 and rs4986790), TLR6
(rs6815827) and TLR9 (rs352139, rs5743842, and rs5743
836) genes were analyzed (See details in Table 2). The
selection of these SNPs was based on their possible func-
tional effect and due to existence of previous associations
with infectious diseases. The SNPs genotyping was per-
formed using the TaqMan 5’ nuclease assay. The PCR
reaction was carried out using 15 ng of DNA, 12.5ul of
2× TaqMan Universal PCR Master Mix, 0.625 ul of 40×
Assay Mix and 8.8ul of ddH20. The genotyping was
performed with validated TaqMan assays (Life Technolo-
gies/Applied Biosystems, Foster City, CA)T L R 2( C _ _
22274563_10, C__29420880_10, Exp:06/2017 30 F04 and
C__27860663_10), TLR4 (C__25761144_10, C___270405
0_10, C__31784003_10 and C__11722238_20), TLR 6 (C__
Table 1 Demographic and clinical characteristics of
patients and controls
TB Patients Controls
(N = 90) (N = 90) P value*
Age 46.9 ± 17.8 42.9 ± 15.9 ns
Gender
M (%) 38 (42.2) 32 (35.5) ns
F (%) 52 (57.7) 58 (64.4) ns
Comorbidities
Type 2 Diabetes n (%) 16/90 (17.7) 0/90 (0) <0.05
Systemic hypertension n (%) 4/90 (4.5) 2/90 (2.2) ns
Immunodeficiency n (%) 1/90 (1.4) 0/90 (0) ns
Autoimmunity n (%) 1/90 (1.4) 0/90 (0) ns
Data are expressed as means ± SD, means and percentage or n
and percentage.
*Comparisons of the continuous variables among groups were performed
using the Mann–Whitney-Wilcoxon test, whereas the X
2 test was used to
compare frequencies.
Table 2 Characteristics of the studied SNPs at TLR2, TLR4,
TLR6 and TLR9 genes
Gene Chr SNP ID Location Genotype
(Phenotype)
TLR2 4 rs3804099 Exon (synonymous) C> T (Asn199Asn)
rs7656411 3′ near gene G> T
rs121917864 Exon
(non-synonymous)
C> T (Arg677Trp)
rs5743708 Exon
(non-synonymous)
A> G (Arg753Gln)
TLR4 9 rs5030710 Exon (synonymous) C> T (Ser105Ser)
rs5030725 Intron G> T
rs12344353 Intron C>T
rs4986790 Exon
(non-synonymous)
A/G (Asp299Gly)
TLR6 4 rs6815827 3′ near gene C> T
TLR9 3 rs352139 Intron A> G
rs5743842 Exon C> T (Arg5Cys)
rs5743836 5′ near gene C> T
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01_10 and C__32645383_10). PCR conditions were: Hold
95°C/10 min, followed by 40 cycles of 92°C/15 s and 60°C/
1 min. All PCR’s were performed using 96-well plates in
a Step One plus real time PCR system (Life Technologies/
Applied Biosystems, Foster City, CA).
Statistical analysis
Demographic and clinical variables between TB patients
and controls were analyzed with the Stata statistical soft-
ware v8.0. We used a significance level of p <0.05. Power
calculation showed that this significance level would
yield a power of 80% with a sample size of 90 individuals
per group. Hardy-Weinberg equilibrium was tested for
all genotypic combinations of each SNP in TB patients
and controls. The differences in the distribution of the
allelic, genotypic and haplotype frequencies of TLR2,
TLR4, TLR6 and TLR9 polymorphisms in TB patients
and controls were evaluated by the Mantel-Haenszel,
Chi-square test with 2x2 contingency tables using the
EPIINFO statistical software v6.04b. p values resulting
from the association analysis were corrected by the
Bonferroni method. Relative risks (RR) with 95% confi-
dence interval (CI) were estimated as the odds ratios
(OR). The significance of the SNPs associated to TB was
adjusted by age, gender and type 2 diabetes (T2D) by lo-
gistic regression analysis and the associations were tested
under dominant and additive models. Pairwise LD was
calculated by the genotype correlation coefficient (r
2).
For all pairs of autosomal SNPs, r
2 measures were calcu-
lated using the software Haploview v4.2 [25].
Results
Demographic and clinical characteristics of TB patients and
controls are summarized in Table 1. Prevalence of T2D was
significantly higher in TB patients (17.7%) when compared
to controls (0%, p < 0.05). Mean age, gender and the preva-
lence of other comorbidities such as systemic hypertension,
immunodeficiency and autoimmunity was similar among
groups.
The gene and genotype frequencies of the TLR2, TLR4,
TLR6 and TLR9 polymorphisms are presented in Table 3.
Significant deviations from the Hardy-Weinberg equilib-
rium in the distribution of the TLRs SNP genotypes in TB
patients and controls were not detected with the exception
of the SNP rs121917864 of TLR2 (X
2 = 88, p < 0.05 in both
TB patients and controls).
We found a significant increase in the frequency of the
allele A of the TLR9 gene polymorphism rs352139 (A>G)
in the group of TB patients (gene frequency (g.f.) = 0.522)
when compared to controls (g.f. = 0.383, Pcorr = 0.01,
OR = 1.75, 95% CI = 1.15-2.67). Under a dominant model
(A/A + A/G vs G/G), this polymorphism was associated
withTB (Pcorr = 0.009, OR = 2.37, 95% CI = 1.22-4.60).
Table 3 Distribution of TLR2, TLR4, TLR6 and TLR9 gene
polymorphisms in patients with TB and controls
TB patients Controls
(N=90) (N=90)
SNP Genotype n F n F Pcorr
Allele
TLR2 rs3804099 T/T 59 (0.656) 48 (0.533) ns
C/T 26 (0.289) 36 (0.400) ns
C/C 5 (0.056) 6 (0.067) ns
T 144 (0.800) 132 (0.733) ns
C 36 (0.200) 48 (0.267) ns
rs7656411 T/T 58 (0.644) 53 (0.589) ns
G/T 29 (0.322) 33 (0.367) ns
G/G 3 (0.033) 4 (0.044) ns
T 145 (0.806) 139 (0.772) ns
G 35 (0.194) 41 (0.228) ns
rs121917864 C/C - - - -
C/T 90 (1.0) 90 (1.0) ns
T/T - - - -
C 90 (0.500) 90 (0.500) ns
T 90 (0.500) 90 (0.500) ns
rs5743708 G/G 90 (1.0) 90 (1.0) ns
G/A - - - -
A/A - - - -
G 180 (1.0) 180 (1.0) ns
A ----
TLR4 rs5030710 T/T 87 (0.967) 87 (0.967) ns
C/T 3 (0.033) 3 (0.033) ns
C/C - - - -
T 177 (0.983) 177 (0.983) ns
C 3 (0.017) 3 (0.017) ns
rs5030725 T/T 86 (0.978) 89 (0.989) ns
T/G 2 (0.022) 1 (0.011) ns
G/G - - - -
T 178 (0.989) 179 (0.994) ns
G 2 (0.011) 1 (0.006) ns
rs12344353 T/T 89 (0.989) 90 (1.0) ns
C/T 1 (0.011) - - ns
C/C - - - -
T 179 (0.994) 180 (1.0) ns
C 1 (0.006) - - ns
rs4986790 A/A 88 (0.978) 89 (0.989) ns
A/G 2 (0.022) 1 (0.011) ns
G/G - - - -
A 178 (0.989) 179 (0.994) ns
G 2 (0.011) 1 (0.006) ns
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the SNP rs352139 was considerably lower in the group
of TB patients (g.f. = 0.211) compared to controls (g.f =
0.389) (Pcorr = 0.01, OR = 0.42, 95% CI = 0.21-0.81).
Consequently the frequency of the allele G was signifi-
cantly higher in the control group (g.f. = 0.617) than in
TB patients (g.f. = 0.478) (Pcorr = 0.01, OR = 0.56, 95%
CI = 0.38-0.86). We also analyzed the distribution of
allele and genotype frequencies of the rs352139 poly-
morphism in males and females from the TB and control
groups. A significant association of the allele A under a
dominant model (A/A + A/G vs G/G) was found with
TB in females (Pcorr = 0.00008, OR = 5.2 (95% CI = 2.3-
12.0).
Importantly, the association of the genotypes of the
SNP rs352139 with TB was confirmed by logistic regres-
sion analysis under the dominant (A/A + G/A vs G/G;
p = 0.01, OR= 2.31, 95% CI= 1.50-4.63) and additive
(2A/A + G/A, to G/G, p = 0.02, OR = 1.68, 95% CI =
1.07-2.65) models after adjustment for age, gender and
T2D, Table 4.
We also compared the distribution of all TLRs SNPs
in TB patients without T2D and controls. The allele A
of the SNP rs352139 was associated to TB in patients
without T2D (Pcorr = 0.02, OR = 1.63, 95% CI = 1.06-
2.57). Also, the dominant model (A/A + A/G vs G/G)
was associated with TB, excluding individuals with T2D
(Pcorr = 0.02, OR = 2.26, 95% CI = 1.12-4.55). Signifi-
cant differences in the distribution of genotypes or
alleles of the TLR9 polymorphisms (rs5743842 and
rs5743836) were not detected.
T h ea l l e l ea n dg e n o t y p ef r e q u e n c i e so ft h eT L R 2
(rs3804099, rs7656411, rs121917864, rs5743708); TLR4
(rs5030710, rs5030725, rs12344353, rs4986790) and TLR6
(rs6815827) polymorphisms were similar amongst TB
patients and controls.
The distribution of TLR2, TLR4 and TLR9 haplotypes
in TB patients and controls are listed in Table 5. We
found a significant association of the haplotype GAA of
TLR9 with TB (TB patients: hf = 0.522 versus Controls:
hf = 0.383; Pcorr = 0.02). No significant differences were
detected in the distribution of TLR2 and TLR4 haplo-
types between TB patients and controls. In general, low
LD (r
2) values were observed for all TLR2, TLR4 and
TLR9 polymorphisms, Figure 1.
Discussion
Several studies have demonstrated that genetic factors
play a major role in the susceptibility to TB [7,8]. Evi-
dence suggests that polymorphisms within TLRs may
cause an impairment of the immune response against
TB; possibly modifying the TLRs affinity to Mtb derived
Table 3 Distribution of TLR2, TLR4, TLR6 and TLR9 gene
polymorphisms in patients with TB and controls
(Continued)
TLR6 rs6815827 C/C 88 (0.978) 88 (0.989) ns
C/T 2 (0.022) 1 (0.011) ns
T/T - - - -
C 178 (0.989) 177 (0.994) ns
T 2 (0.011) 1 (0.006) ns
TLR9 rs352139 G/G 19 (0.211) 35 (0.389) 0.01
*
A/G 48 (0.533) 41 (0.456) ns
A/A 23 (0.256) 14 (0.156) ns
G 86 (0.478) 111 (0.617) 0.01
**
A 94 (0.522) 69 (0.383) 0.01
***
rs5743842 T/T - - - -
T/C 2 (0.022) - - ns
C/C 88 (0.978) 90 (1.0) ns
T 2 (0.011) - - ns
C 178 (0.989) 180 (1.0) ns
rs5743836 T/T 82 (0.911) 78 (0.867) ns
T/C 8 (0.089) 12 (0.133) ns
C/C - - - -
T 172 (0.956) 168 (0.933) ns
C 8 (0.044) 12 (0.067) ns
* OR = 0.42, 95% CI = 0.21-0.81.
** OR = 0.56, 95% CI = 0.38-0.86.
*** OR = 1.75, 95% CI = 1.15-2.67.
ns: non significant; F: frequency; Pcorr: p values were corrected by Bonferroni.
Statistically significant values are shown in bold.
Table 4 Association of the TLR9 polymorphism rs352139 (A>G) genotypes with pulmonary TB after logistic
regression analysis
Genotype frequency (%)
G/G G/A A/A MAF (A) Model OR (95% CI) P value
Control (n = 90) 0.389 0.456 0.156 0.383
TB (n = 90) 0.211 0.533 0.256 0.522 Dominant (A/A + G/A vs G/G) 2.31 (1.50-4.63) 0.016
Additive (2A/A + G/A, to G/G) 1.68 (1.07-2.65) 0.023
Associations were tested using logistic regression adjusting for Age, Gender and T2D.
TB: Tuberculosis; MAF: Minor allele frequency. Statistically significant values are shown in bold.
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of anti-Mtb immune responses [13,16]. These studies
have been performed in different populations including
Asians, African-Americans and Caucasians, but the
results of genetic association studies are controversial
[14-24]. Recent studies suggest that TLRs polymor-
phisms might not contribute markedly to TB susceptibil-
ity [21,26]. However, the current study provides evidence
that TLRs polymorphisms contribute to pulmonary TB
susceptibility in Mexicans. We found a significant associ-
ation of the allele A of the SNP rs352139 (A>G) located
in the intronic region of TLR9, on chromosome 3, with
the susceptibility to TB in patients from a rural area in
the State of Oaxaca in the southeast of Mexico. The asso-
ciation of this SNP was confirmed by logistic regression
analysis, adjusting for age, gender and T2D. A significant
association with the dominant A/A + A/G vs GG with
TB was also detected and particularly with female. A de-
creased frequency of the homozygous genotype G/G of
the SNP rs352139 was detected in the group of TB
patients, suggesting a protective role of the allele G.
Moreover, the TLR9 haplotype containing the allele A
of this SNP (Haplotype GAA) was associated with the
susceptibility to TB.
TLR9 is expressed by different cells of the immune
system and is essential in the activation of the innate
responses against Mtb infection [9]. TLR9 recognizes
unmethylated CpG DNA motifs and functional studies
revealed that the binding of TLR9 is necessary to drive
the Th1 immune response [27]. The importance of
TLR9 in the antimycobacterial responses has been sup-
ported in experimental models using the TLR9-deficient
mice [9,10].
In line with our results, the allele A of the SNP
rs352139 has been strongly associated with susceptibility
to TB in African-Americans but not with Caucasians
and African patients from Guinea-Bissau [17]. Func-
tional studies suggest that the intronic TLR9 polymorph-
ism rs352139 A>G exerts a regulatory effect of TLR9
Table 5 Haplotype distribution of TLR2, TLR4 and TLR9
polymorphisms in patients with TB and controls
Haplotypes* TB patients Controls X
2 Pcorr
(N = 90) (N = 90)
hf hf
TLR2
TTGT 0.349 0.324 0.243 ns
TCGT 0.349 0.324 0.243 ns
CTGG 0.046 0.071 1.053 ns
CCGG 0.046 0.071 1.053 ns
CTGT 0.054 0.062 0.103 ns
CCGT 0.054 0.062 0.103 ns
TTGG 0.051 0.042 0.154 ns
TCGG 0.051 0.042 0.154 ns
TLR4
TTTA 0.972 0.972 0.0 ns
TTCA 0.011 0.017 0.203 ns
TLR9
GGA 0.433 0.550 4.901 ns
GAA 0.522 0.383 7.007 0.02
GGG 0.033 0.067 2.105 ns
*Haplotypes: TLR2 [rs3804099, rs121917864, rs5743708, rs7656411].
TLR4 [rs12344353, rs5030725, rs5030710, rs4986790].
TLR9 [rs5743842, rs352139, rs5743836].
ns: non significant, hf: haplotype frequency. Statistically significant values are
shown in bold.
Figure 1 Linkage disequilibrium (LD) plots of TLR2, TLR4 and TLR9 polymorphisms containing the significant single-nucleotide
polymorphism of TLR9 (rs352139 (A>G) associated with pulmonary TB. The LD plots were generated using Haploview v4.2 (Broad Institute,
Cambridge, MA, USA) [25]. Numbers in squares indicate the correlation (r
2) between SNPs.
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allele of the promoter polymorphism −1486, is associ-
ated with downregulation the TLR9 expression at the
transcriptional level. In contrast, the presence of the
allele A (in presence of the allele T of the promoter poly-
morphism T allele at −1486) induces the up-regulation of
TLR9 expression [28]. It is possible that this variation influ-
ences signaling by creating an alternative splicing site,
affecting the TLR9 mRNA transcription. Otherwise, the
rs352139 SNP could be a likely marker in LD with a poly-
morphic regulatory region that controls TLR9 expression
or a functional coding region polymorphism [28]. However,
the effect of this intronic SNP in the induction or down-
regulation of TLR9 expression is not well defined, particu-
larly in the context of infectious diseases.
Different from other pathogens, Mtb infection can
persist in the host for long periods in a dormant or latent
state, even in a fully functioning immune system [29]. TB
immunity is mediated by Th1-type responses; nevertheless
this response is apparently not enough to definitively
eradicate the chronic infection or the latent bacilli [30].
It is possible that the presence of the allele A of the
rs352139 SNP in individuals with latent TB infection may
result in a high TLR9 expression that contribute to the in-
duction of high levels of proinflammatory cytokines. A
pro-inflammatory environment in lung confers protection
against Mtb infection. However, a pathogenic or exacer-
bated pulmonary inflammation may exert deleterious ef-
fects [31], promoting the infiltration inflammatory cells to
the lung that become Mtb infected. A dysregulated inflam-
matory environment, potentially can also contribute to the
tissue damage and dissemination of the mycobacteria to
other areas of the lung and peripheral tissues. It is import-
ant to remark that the allele A of this polymorphism of
TLR9 has been associated with the susceptibility and se-
verity of parasitic and viral infections [32,33].
Interestingly, the polymorphism rs352139, located in
the intronic region of TLR9, has been associated with
the susceptibility to TB in Indonesian females [14].
Besides, it is noteworthy that this polymorphism was
associated with pulmonary TB in females from South
India [34]. In our study, we found a significant associ-
ation of this polymorphism, particularly the homozygous
A/A and heterozygous A/G genotypes, with the suscepti-
bility to TB in females. The reason why these genotypes
contribute to the susceptibility to TB in females is not
fully clear. In this regard, previous studies have sug-
gested that significant differences exist in TB incidence
between males and females [35,36]. The physiological
hypothesis of infectious diseases susceptibility, suggest
that differences in the expression of sex hormones and
genetic variability between males and females might
contribute in the differential incidence of infectious dis-
eases among them [37]. Moreover, in vitro studies have
revealed that progesterone regulates the production of
type I interferon (IFN-α), possibly through the interference
of MyD88-dependent activation of interferon regulatory
factor 7 (IRF-7) after stimulation with the TLR9 ligand
CpG in both, mice and humans. Consequently, the inhibi-
tory effect of this female sex steroid hormone on IFN-α
production may impair inflammatory responses and pat-
tern recognition receptor signaling against pathogens [38].
From the population genetics perspective, it is interest-
ing that this SNP is associated with susceptibility to TB
across Asian and Amerindian groups. The Mazatecans
inhabit the mountains of northern Oaxaca (Mexico).
They belong to the ancient Central-American cultural
groups and may be related to the Olmecs (the most
ancient Meso-American culture). The first Amerindian
Natives are believed to have come from Asia through
the Bering land bridge between 30,000–12,000 years
before the present. These assumptions have been based on
cultural, morphological and genetic connections between
Native American and Asian populations [39-41]. Sup-
porting the hypothesis of the presence of Asian genes in
Amerindian populations, in previous published studies
we have detected Asian haplotypes (HLA-DRB1*15:02-
DQB1*0602) in Mazatecans [42]. Also, a short genetic
distance between Chinese and Native Americans was
detected using Alu insertions data [43]. Anthropological
genetic studies have suggested that some Asian genes may
have been introduced to Native Americans by a Trans-
Pacific route of migration from South East Asian popula-
tions [44,45].
Our study has some limitations, including its relatively
small sample size, restricted by the study’s focus on
patients from Amerindian ancestry with a recent diagno-
sis of pulmonary TB. In addition, we chose not to in-
clude individuals with familial history of autoimmune
and neoplastic disorders. The second limitation is the
lack of functional assays to determine the effect of TLR9
variation in the susceptibility to pulmonary TB. The
strengths of our study includes the analysis of the influ-
ence of TLRs polymorphisms in the susceptibility to TB
in a well genetically characterized ethnic group of Mexi-
can Amerindians and the replication of the associations
of the TLR9 intronic polymorphism previously described
in other Asian ethnic groups.
Conclusions
In summary, our findings suggest that the allele A of the
polymorphism rs352139, located in the intronic region of
the TLR9 gene could be implicated in the susceptibility to
TB in Mazatecan Amerindians from the Oaxaca State in
Mexico. Additional studies in a large number of TB pa-
tients and functional studies may help to establish the true
significance and the possible deleterious effect of this poly-
morphism in the susceptibility to pulmonary TB.
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